Table 14.
Dose (mg/kg/day) | Animals per dose | MNPCE/2000 PCE (Mean ± S.D) | PCE:RBC Ratio (Mean ± S.D) | % Ratio |
---|---|---|---|---|
| ||||
0 | 6 | 1.17 ± 0.75 | 0.40 ± 0.02 | 100 |
1250 | 6 | 0.83 ± 0.98 | 0.38 ± 0.03 | 95 |
2500 | 6 | 0.83 ± 0.75 | 0.37 ± 0.03 | 93 |
5000 | 6 | 0.83 ± 0.75 | 0.39 ± 0.02 | 98 |
CPA 70 (mg/kg) | 6 | 61.00 ± 5.18** | 0.21 ± 0.03** | 53 |
PCE; Polychromatic erythrocyte, RBC; Red blood cells (polychromatic erythrocyte + normochromatic erythrocyte), MNPCE; Micronucleated polychromatic erythrocyte, CPA; Cyclophosphamide monohydrate.
Vehicle and Test article were orally administered to mice for two consecutive days.
CPA was intraperitoneally administered to mice once on the day of the 2nd admin.
Bone marrow smears were prepared about 24 hr after the final administration.
** Significantly different from the negative control group at p<0.01.